Carregant...
A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease
A paradigm shift has emerged in Parkinson’s disease (PD) highlighting the prominent role of CD4(+) Tregs in pathogenesis and treatment. Bench to bedside research, conducted by others and our own laboratories, advanced a neuroprotective role for Tregs making pharmacologic transformation of immediate...
Guardat en:
| Publicat a: | Front Cell Neurosci |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6759633/ https://ncbi.nlm.nih.gov/pubmed/31619964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2019.00421 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|